LNK754 is primarily used in the field of medical research, particularly in the development of treatments for metabolic disorders. It has shown potential in regulating glucose metabolism, making it a candidate for studies focused on diabetes management. Researchers are exploring its ability to modulate specific pathways that influence insulin sensitivity and glucose uptake in cells. Additionally, it is being investigated for its role in addressing lipid metabolism abnormalities, which could be beneficial in managing conditions like obesity and hyperlipidemia. Its application in preclinical studies aims to uncover its therapeutic efficacy and safety profile for future clinical use.